Detalhe da pesquisa
1.
Rituximab or cyclosporine a for the treatment of membranous nephropathy: Economic evaluation of the MENTOR trial.
Nephrol Dial Transplant
; 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38621719
2.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Kidney Int
; 103(2): 391-402, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36270561
3.
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Kidney Int
; 103(3): 565-579, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36442540
4.
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
Kidney Int
; 104(6): 1092-1102, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37795587
5.
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease.
Am J Kidney Dis
; 81(3): 318-328.e1, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36191724
6.
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis.
Nephrol Dial Transplant
; 38(4): 950-960, 2023 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35948275
7.
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.
Kidney Int
; 102(1): 160-172, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35490842
8.
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
N Engl J Med
; 381(1): 36-46, 2019 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31269364
9.
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 79(4): 570-581, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34571062
10.
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
J Am Soc Nephrol
; 32(2): 436-447, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33514642
11.
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
JAMA
; 327(19): 1888-1898, 2022 05 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35579642
12.
Updating the International IgA Nephropathy Prediction Tool for use in children.
Kidney Int
; 99(6): 1439-1450, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33220356
13.
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
Am J Nephrol
; 52(10-11): 827-836, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34731857
14.
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.
Kidney Int
; 98(4): 1009-1019, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32464215
15.
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Nephrol Dial Transplant
; 35(6): 1002-1009, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30418652
16.
How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy.
BMC Med Inform Decis Mak
; 20(1): 231, 2020 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32938443
17.
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int
; 95(2): 281-295, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30665569
18.
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int
; 95(2): 268-280, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30665568
19.
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
Nephrol Dial Transplant
; 34(10): 1681-1690, 2019 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30561721
20.
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study.
Am J Physiol Renal Physiol
; 314(3): F412-F422, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29141939